Armata Pharmaceuticals, Inc. Quarterly Common Stock, Shares Authorized from Q4 2013 to Q3 2024

Taxonomy & unit
us-gaap: shares
Description
The maximum number of common shares permitted to be issued by an entity's charter and bylaws.
Summary
Armata Pharmaceuticals, Inc. quarterly Common Stock, Shares Authorized history and growth rate from Q4 2013 to Q3 2024.
  • Armata Pharmaceuticals, Inc. Common Stock, Shares Authorized for the quarter ending September 30, 2024 was 217M shares, unchanged year-over-year.
Common Stock, Shares Authorized, Quarterly (shares)
Common Stock, Shares Authorized, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 217M 0 0% Sep 30, 2024 10-Q 2024-11-13
Q2 2024 217M 0 0% Jun 30, 2024 10-Q 2024-08-13
Q1 2024 217M 0 0% Mar 31, 2024 10-Q 2024-05-07
Q4 2023 217M 0 0% Dec 31, 2023 10-Q 2024-11-13
Q3 2023 217M 0 0% Sep 30, 2023 10-Q 2023-11-14
Q2 2023 217M 0 0% Jun 30, 2023 10-Q 2023-08-14
Q1 2023 217M 0 0% Mar 31, 2023 10-Q 2023-05-11
Q4 2022 217M 0 0% Dec 31, 2022 10-K 2024-03-21
Q3 2022 217M 0 0% Sep 30, 2022 10-Q 2022-11-09
Q2 2022 217M 0 0% Jun 30, 2022 10-Q 2022-08-11
Q1 2022 217M 0 0% Mar 31, 2022 10-Q 2022-05-12
Q4 2021 217M 0 0% Dec 31, 2021 10-K 2023-03-16
Q3 2021 217M 0 0% Sep 30, 2021 10-Q 2021-11-10
Q2 2021 217M 0 0% Jun 30, 2021 10-Q 2021-08-12
Q1 2021 217M 0 0% Mar 31, 2021 10-Q 2021-05-13
Q4 2020 217M 0 0% Dec 31, 2020 10-K 2022-03-17
Q3 2020 217M 0 0% Sep 30, 2020 10-Q 2020-11-12
Q2 2020 217M 0 0% Jun 30, 2020 10-Q 2020-08-13
Q1 2020 217M 0 0% Mar 31, 2020 10-Q 2020-05-14
Q4 2019 217M 0 0% Dec 31, 2019 10-K 2021-03-18
Q3 2019 217M +150M +224% Sep 30, 2019 10-Q 2019-11-12
Q2 2019 217M +150M +224% Jun 30, 2019 10-Q 2019-08-14
Q1 2019 217M +150M +224% Mar 31, 2019 10-Q 2019-05-06
Q4 2018 217M +150M +224% Dec 31, 2018 10-K 2020-03-19
Q3 2018 67M 0 0% Sep 30, 2018 10-Q 2018-11-08
Q2 2018 67M 0 0% Jun 30, 2018 10-Q 2018-08-09
Q1 2018 67M 0 0% Mar 31, 2018 10-Q 2018-05-15
Q4 2017 67M 0 0% Dec 31, 2017 10-K 2019-03-25
Q3 2017 67M -603M -90% Sep 30, 2017 10-Q 2017-11-14
Q2 2017 67M -603M -90% Jun 30, 2017 10-Q 2017-08-14
Q1 2017 67M -603M -90% Mar 31, 2017 10-Q 2017-05-15
Q4 2016 67M -603M -90% Dec 31, 2016 10-K 2018-03-14
Q3 2016 670M 0 0% Sep 30, 2016 10-Q 2016-11-10
Q2 2016 670M +225M +50.6% Jun 30, 2016 10-Q 2016-08-15
Q1 2016 670M +225M +50.6% Mar 31, 2016 10-Q 2016-05-12
Q4 2015 670M 0 0% Dec 31, 2015 10-K 2017-03-27
Q3 2015 670M +225M +50.6% Sep 30, 2015 10-Q 2015-11-16
Q2 2015 445M 0 0% Jun 30, 2015 10-Q 2015-08-13
Q1 2015 445M 0 0% Mar 31, 2015 10-Q 2015-05-15
Q4 2014 670M +225M +50.6% Dec 31, 2014 10-K 2016-03-30
Q3 2014 445M Sep 30, 2014 10-Q/A 2015-04-15
Q2 2014 445M Jun 30, 2014 10-Q/A 2015-04-15
Q1 2014 445M Mar 31, 2014 10-Q/A 2015-04-15
Q4 2013 445M Dec 31, 2013 10-K 2015-04-15
* An asterisk sign (*) next to the value indicates that the value is likely invalid.